Thrombolytic therapy for ischemic stroke: from clinical trials to clinical practice

Editorial

J P Mohr. JAMA. 2000.

. 2000 Mar 1;283(9):1189-91.

doi: 10.1001/jama.283.9.1189.

No abstract available

Comment on

Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Albers GW, et al. JAMA. 2000 Mar 1;283(9):1145-50. doi: 10.1001/jama.283.9.1145. JAMA. 2000. PMID: 10703776 Clinical Trial.
Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience.
Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, Hammel JP, Qu A, Sila CA. Katzan IL, et al. JAMA. 2000 Mar 1;283(9):1151-8. doi: 10.1001/jama.283.9.1151. JAMA. 2000. PMID: 10703777